Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSKP.L Regulatory News (SKP)

  • There is currently no data for SKP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

14 Jul 2009 11:08

RNS Number : 6236V
Skyepharma PLC
14 July 2009
 



TR-1: notification of major interests in shares 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

SkyePharma plc

2. Reason for the notification   (please tick the appropriate box or boxes)

An acquisition or disposal of voting rights 

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An event changing the breakdown of voting rights

Other (please specify):___Increase in Shares Outstanding___________

3. Full name of person(s) subject to the notification obligation:

OrbiMed Advisors LLC

4. Full name of shareholder(s) (if different from 3.):

Caduceus Capital Master Fund Limited

 Caduceus Capital II, L.P.

UBS Eucalyptus Fund, L.L.C

PW Eucalyptus Fund, Ltd.

Summer street Life Sceinces Hedge Fund Investors LLC

5. Date of the transaction (and date on which the threshold is crossed or reached if different):

June 30, 2009

6. Date on which issuer notified:

July 13, 2009

7. Threshold(s) that is/are crossed or reached:

11.5%

8. Notified details:

A: Voting rights attached to shares

Class/type of shares 

 if possible using the ISIN CODE

Situation previous to the Triggering transaction 

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares 

Number of voting rights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

 GB00B3BFNB64

n/a

n/a

2,747,242

 

2,747,242

11.5%

B: Financial Instruments

Resulting situation after the triggering transaction xii

Type of financial instrument 

Expiration date

Exercise/ Conversion Period/ Date 

Number of voting rights that may be acquired if the instrument is exercised/ converted. 

% of voting rights

Total (A+B)

Number of voting rights

% of voting rights

2,747,242

11.5%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

Not Applicable

Proxy Voting:

10. Name of the proxy holder:

Not Applicable

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:

Not Applicable

14. Contact name:

Eric Bittelman

15. Contact telephone number:

001-212-739-6400

Annex Notification Of Major Interests In Shares

A: Identity of the person or legal entity subject to the notification obligation

Full name (including legal form for legal entities)

Contact address (registered office for legal entities)

Phone number 

Other useful information (at least legal representative for legal persons)

 B:  Identity of the notifier, if applicable

Full name 

Contact address 

Phone number 

Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation)

 C: Additional information

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLBZLFFKDBBBBE
Date   Source Headline
9th Jun 20161:03 pmRNSForm 8.3 - Vectura Group Plc
9th Jun 201612:00 pmRNSForm 8.5 (EPT/RI) - Skyepharma Plc
9th Jun 201612:00 pmRNSForm 8.5 (EPT/RI) - Vectura Group PLC
9th Jun 201610:54 amRNSCourt sanction of Scheme of Arrangement
9th Jun 201610:51 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
9th Jun 20168:52 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
8th Jun 201612:25 pmRNSForm 8.5 (EPT/RI) - Skyepharma PLC Amendment
8th Jun 201612:00 pmRNSForm 8.5 (EPT/RI) - Vectura Group PLC
8th Jun 201612:00 pmRNSForm 8.5 (EPT/RI) - Skyepharma Plc
8th Jun 201610:24 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
8th Jun 20169:20 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
8th Jun 20168:32 amRNSHolding(s) in Company
7th Jun 20162:56 pmRNSTechnology License Agreement
7th Jun 20162:02 pmRNSForm 8.3 - Skyepharma Plc
7th Jun 20161:05 pmRNSForm 8.5 (EPT/RI) - Vectura Group PLC
7th Jun 201611:21 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
7th Jun 20169:06 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
6th Jun 20163:34 pmRNSForm 8.3 - Skyepharma Plc
6th Jun 20163:30 pmRNSForm 8.3 - [VEC/SKP]
6th Jun 20163:30 pmRNSForm 8.3 - [SKP/VEC]
6th Jun 20163:09 pmRNSForm 8.3 - [Skyepharma plc]
6th Jun 20162:51 pmRNSForm 8.3 - SKYEPHARMA PLC
6th Jun 20162:14 pmRNSForm 8.3 - Skyepharma Plc
6th Jun 20161:23 pmRNSForm 8.3 - Skyepharma Plc
6th Jun 201612:00 pmRNSForm 8.5 (EPT/RI) -Vectura Group PLC
6th Jun 201612:00 pmRNSForm 8.5 (EPT/RI) - Skyepharma Plc
6th Jun 201610:59 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
6th Jun 201610:03 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
6th Jun 20168:35 amRNSForm 8.3 - Vectura Group plc
3rd Jun 20163:30 pmRNSForm 8.3 - [VEC/SKP]
3rd Jun 20163:30 pmRNSForm 8.3 - [SKP/VEC]
3rd Jun 20163:20 pmRNSForm 8.3 - Skyepharma PLC
3rd Jun 20161:45 pmRNSForm 8.3 - Skyepharma Plc
3rd Jun 20161:23 pmRNSForm 8.3 - Skyepharma Plc
3rd Jun 201611:59 amRNSForm 8.5 (EPT/RI) - Vectura Group PLC
3rd Jun 201611:59 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
3rd Jun 201610:28 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
3rd Jun 20169:45 amRNSForm 8.3 - Skyepharma PLC
3rd Jun 20169:31 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
2nd Jun 20163:30 pmRNSForm 8.3 - [VEC/SKP]
2nd Jun 20163:30 pmRNSForm 8.3 - [SKP/VEC]
2nd Jun 20163:20 pmRNSForm 8.3 - Skyepharma PLC
2nd Jun 20161:33 pmRNSForm 8.3 - Skyepharma Plc
2nd Jun 201612:00 pmRNSForm 8.5 (EPT/RI) - Skyepharma Plc
2nd Jun 201612:00 pmRNSForm 8.5 (EPT/RI) - ve
2nd Jun 201610:32 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
2nd Jun 20169:54 amRNSForm 8.3 - Skyepharma PLC
2nd Jun 20169:10 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
1st Jun 20163:30 pmRNSForm 8.3 - [SKP/VEC]
1st Jun 20163:30 pmRNSForm 8.3 - [VEC/SKP]

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.